Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Topstories https://ift.tt/3nX8fwP
https://ift.tt/eA8V8J
Thursday, October 15, 2020
Home »
» Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO
0 comments:
Post a Comment